Start of Vetter’s $300M U.S. sterile plant project delayed for years

Construction of German CDMO Vetter’s new sterile injectables manufacturing facility—part of its $320 million plan to invest in a U.S. site in the Chicago area—appears to be getting pushed back until 2022.Original Article